⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of OneSource Specialty Pharma Limited and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
OneSource Specialty Pharma Limited
↗Bengaluru, India
OneSource Specialty Pharma Limited is an India-based, pure-play specialty pharmaceutical CDMO. Formed through the integration of legacy businesses (Stelis Biopharma, SteriScience, and Strides' soft gelatin business), the company provides end-to-end development and manufacturing services for complex pharmaceutical products.
The company specializes in biologics, drug-device combinations, sterile injectables, and soft gelatin capsules. Operating from multiple state-of-the-art, globally approved manufacturing facilities in Bengaluru, OneSource supports global pharmaceutical partners from early-stage development through clinical trials and commercial supply.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$163M (TTM)
Founded:2023
Ownership:public
Status:operating
FUNDING
Total Raised:$95M
Investors:Domestic and foreign institutional investors, Family offices
STOCK
Exchange:BSE
Ticker:544292
Market Cap:$2.12B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Manufacturing partner for generic Ozempic/Semaglutide)
Modalities:Small molecule, Biologics, Drug-device combinations, Soft gelatin capsules
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Strides Pharma Science (Associate company)
Key Partnerships:Orbicular Pharmaceutical Technologies (Generic Semaglutide), Dr. Reddy's Laboratories (Generic Semaglutide)
COMPETITION
Position:Emerging
Competitors:Piramal Pharma Solutions, Lupin Manufacturing Solutions, Cambrex, Aurigene Pharmaceutical Services
LEADERSHIP
Key Executives:
Neeraj Sharma - CEO and Managing Director
LINKS
Website:onesourcecdmo.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with OneSource Specialty Pharma Limited. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.